SPONSOR
BillionToOne Inc.
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Pregnant IndividualsAneuploidyDown Syndrome (Trisomy 21)22q11.2 Deletion SyndromeTrisomy 13Trisomy 18Sex Chromosome Abnormalities
BillionToOne Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21), 22q11.2 Deletion Syndrome.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — BillionToOne Inc.
How many clinical trials has BillionToOne Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by BillionToOne Inc., of which 1 are actively recruiting participants. These trials cover conditions including Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does BillionToOne Inc. research focus on?
BillionToOne Inc. clinical trials span Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21), 22q11.2 Deletion Syndrome, Trisomy 13, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a BillionToOne Inc. clinical trial?
To participate in a BillionToOne Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all BillionToOne Inc. trials with current recruitment status updated daily.
Clinical Trials by BillionToOne Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology